Literature DB >> 33783320

Emerging views of OPTN (optineurin) function in the autophagic process associated with disease.

Yueping Qiu1, Jincheng Wang1, Hui Li1, Bo Yang2, Jiajia Wang1, Qiaojun He1,3, Qinjie Weng1,3.   

Abstract

Macroautophagy/autophagy is a highly conserved process in eukaryotic cells. It plays a critical role in cellular homeostasis by delivering cytoplasmic cargos to lysosomes for selective degradation. OPTN (optineurin), a well-recognized autophagy receptor, has received considerable attention due to its multiple roles in the autophagic process. OPTN is associated with many human disorders that are closely related to autophagy, such as rheumatoid arthritis, osteoporosis, and nephropathy. Here, we review the function of OPTN as an autophagy receptor at different stages of autophagy, focusing on cargo recognition, autophagosome formation, autophagosome maturation, and lysosomal quality control. OPTN tends to be protective in most autophagy associated diseases, though the molecular mechanism of OPTN regulation in these diseases is not well understood. A comprehensive review of the function of OPTN in autophagy provides valuable insight into the pathogenesis of human diseases related to OPTN and facilitates the discovery of potential key regulators and novel therapeutic targets for disease intervention in patients with autophagic diseases.Abbreviations: ATG: autophagy-related; APAP: acetaminophen; CALCOCO2/NDP52: calcium binding and coiled-coil domain 2; CC: coiled-coil; HACE1: HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1; MYO6: myosin VI; IKBKG/NEMO: inhibitor of nuclear factor kappa B kinase regulatory subunit gamma; IKK: IκB kinase; LIR: LC3-interacting region; LZ: leucine zipper; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; NFKB/NF-κB: nuclear factor kappa B subunit; OPTN: optineurin; PIK3C3: phosphatidylinositol 3-kinase catalytic subunit type 3; PINK1: PTEN induced kinase 1; PRKN: parkin RBR E3 ubiquitin protein ligase; RTECs: renal tubular epithelial cells; SQSTM1/p62: sequestosome 1; TBK1: TANK binding kinase 1; TOM1: target of myb1 membrane trafficking protein; UBD: ubiquitin-binding domain; ULK1: unc-51 like autophagy activating kinase 1; WIPI2: WD repeat domain, phosphoinositide interacting 2; ZF: zinc finger.

Entities:  

Keywords:  Autophagy; autophagosome formation; cargo recognition; diseases; lysosomal quality control; mitophagy; optineurin (OPTN)

Mesh:

Substances:

Year:  2021        PMID: 33783320      PMCID: PMC8865304          DOI: 10.1080/15548627.2021.1908722

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  137 in total

1.  Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes.

Authors:  Andrew R J Young; Edmond Y W Chan; Xiao Wen Hu; Robert Köchl; Samuel G Crawshaw; Stephen High; Dale W Hailey; Jennifer Lippincott-Schwartz; Sharon A Tooze
Journal:  J Cell Sci       Date:  2006-08-29       Impact factor: 5.285

Review 2.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 3.  Optineurin: The autophagy connection.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Exp Eye Res       Date:  2015-07-02       Impact factor: 3.467

4.  Neurodegenerative diseases.

Authors:  Marie-Thérèse Heemels
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 5.  Biological Functions of Autophagy Genes: A Disease Perspective.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

6.  Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin.

Authors:  Pieter H Anborgh; Christina Godin; Macarena Pampillo; Gurpreet K Dhami; Lianne B Dale; Sean P Cregan; Ray Truant; Stephen S G Ferguson
Journal:  J Biol Chem       Date:  2005-08-09       Impact factor: 5.157

Review 7.  Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy.

Authors:  Vladimir Rogov; Volker Dötsch; Terje Johansen; Vladimir Kirkin
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

8.  IRF-1-binding site in the first intron mediates interferon-γ-induced optineurin promoter activation.

Authors:  Cherukuri Sudhakar; Vipul Vaibhava; Ghanshyam Swarup
Journal:  Biochem Biophys Res Commun       Date:  2013-06-27       Impact factor: 3.575

9.  Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome.

Authors:  David A Tumbarello; Bennett J Waxse; Susan D Arden; Nicholas A Bright; John Kendrick-Jones; Folma Buss
Journal:  Nat Cell Biol       Date:  2012-09-30       Impact factor: 28.824

Review 10.  The Selective Autophagy Receptor Optineurin in Crohn's Disease.

Authors:  Markus Tschurtschenthaler; Timon Erik Adolph
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

View more
  4 in total

1.  Optineurin promotes myogenesis during muscle regeneration in mice by autophagic degradation of GSK3β.

Authors:  Xiao Chen Shi; Bo Xia; Jian Feng Zhang; Rui Xin Zhang; Dan Yang Zhang; Huan Liu; Bao Cai Xie; Yong Liang Wang; Jiang Wei Wu
Journal:  PLoS Biol       Date:  2022-04-27       Impact factor: 9.593

2.  Leonurine Protects Bone Mesenchymal Stem Cells from Oxidative Stress by Activating Mitophagy through PI3K/Akt/mTOR Pathway.

Authors:  Bingkun Zhao; Qian Peng; Dan Wang; Rong Zhou; Raorao Wang; Yizhun Zhu; Shengcai Qi
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

3.  Sirt5-mediated desuccinylation of OPTN protects retinal ganglion cells from autophagic flux blockade in diabetic retinopathy.

Authors:  Ye Zhang; Tingting Li; Xuan Cai; Da Long; Xiangning Wang; Chang Liu; Qiang Wu
Journal:  Cell Death Discov       Date:  2022-02-14

4.  Optineurin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration.

Authors:  Zhilei Hu; Yu Wang; Xiaoxin Gao; Yuyao Zhang; Chenhao Liu; Yu Zhai; Xian Chang; Haiyin Li; Yueyang Li; Jinhui Lou; Changqing Li
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.